Zobrazeno 1 - 10
of 1 146
pro vyhledávání: '"Hope S Rugo"'
Autor:
Michael J Campbell, Hope S Rugo, Chiun-Sheng Huang, Chun-Yen Lin, Jung-Tung Hung, I-Ju Chen, Shir-Hwa Ueng, Shin-Cheh Chen, Mu-Yi Chen, Yung-Chang Lin, Alice L Yu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/89c1a2bb641f4bd6abe6049e9723de97
Autor:
Saumya Umashankar, Matina Elise Mamounas, Madeline Matthys, Edward Kenji Hadeler, Emily Claire Wong, Greg Hicks, Jimmy Hwang, Amy Jo Chien, Hope S Rugo, Deborah Hamolsky, Laura Esserman, Michelle Melisko
Publikováno v:
JMIR Cancer, Vol 8, Iss 1, p e31756 (2022)
BackgroundPatients with breast cancer frequently experience escalation of anxiety after completing curative treatment. ObjectiveThis study evaluated the acceptability and psychological impact of a 1-day workshop to emphasize behavioral strategies in
Externí odkaz:
https://doaj.org/article/4237cee0b1314dd786c38793f0b70b24
Autor:
Hope S Rugo, Antonino Musolino, William J Gradishar, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/84020c9f8fdf4430910e9aaa577cdc59
Autor:
Sara M Tolaney, Leisha A Emens, Mary L Disis, David B Page, Heather L McArthur, Ashley Cimino-Mathews, Sylvia Adams, Elizabeth A Mittendorf, Rita Nanda, Hope S Rugo, Margaret E Gatti-Mays, Krista M Rubin, Alice Y Ho, Kevin Kalinsky, Hatem Soliman, Patricia A Spears, Jennifer K Litton
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Breast cancer has historically been a disease for which immunotherapy was largely unavailable. Recently, the use of immune checkpoint inhibitors (ICIs) in combination with chemotherapy for the treatment of advanced/metastatic triple-negative breast c
Externí odkaz:
https://doaj.org/article/125c7af196284dd687fca449c5dbba16
Autor:
Sung-Bae Kim, Hope S Rugo, Sara A Hurvitz, Hong-Tai Chang, Chiun-Sheng Huang, Su-Hua Lee, Jung-Tung Hung, Shir-Hwa Ueng, Shin-Cheh Chen, Alice L Yu, Ling-Ming Tseng, Louis W C Chow, Ming-Feng Hou, Richard B Schwab, James L Murray, Hsien-Kun Chang, Chwen-Cheng Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Purpose This randomized, double-blind, placebo-controlled, parallel-group, phase II trial assessed the efficacy and safety of adagloxad simolenin (OBI-822; a Globo H epitope covalently linked to keyhole limpet hemocyanin (KLH)) with adjuvant OBI-821
Externí odkaz:
https://doaj.org/article/6edfc74c39b5454884784f7a49c0a626
Autor:
Anand Dhruva MD, Cairn Wu BA, Christine Miaskowski RN, PhD, Wendy Hartogensis Phd, MPH, Hope S Rugo MD, Shelley R Adler PhD, Ted J Kaptchuk, Rucha Kelkar BAMS, PT, DPT, Sangeeta Agarawal RN, MS, CAS, Amisha Vadodaria BA, Ellen Garris CAS, Frederick M Hecht MD
Publikováno v:
Global Advances in Health and Medicine, Vol 9 (2020)
Purpose Ongoing symptoms and impairments in quality of life (QOL) among breast cancer survivors remain a significant problem. We tested the feasibility and acceptability of a manualized Ayurvedic nutrition and lifestyle intervention for breast cancer
Externí odkaz:
https://doaj.org/article/94458066dc3c417f87483585ccb5b091
Autor:
Ahmad Awada, Jean-Pascal Machiels, Sylvie Rottey, Sabino De Placido, Massimo Cristofanilli, Javier Cortes, Miguel Martin, Marco Tagliamento, Marc Peeters, Mario Campone, Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Vivianne Tjan-Heijnen, Sara A Hurvitz, Guy Berchem, Rupert Bartsch, Fabio Puglisi, Volkmar Müller, Thomas Ruhstaller, PierFranco Conte
Publikováno v:
ESMO Open, Vol 5, Iss 4 (2020)
Background COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major onc
Externí odkaz:
https://doaj.org/article/7ae15fc0dc8e40fd90d140a116a2dbd1
Autor:
Seock-Ah Im, Javier Cortes, David W. Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S. Rugo, Peter Schmid
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract In the phase 3 KEYNOTE-355 study (NCT02819518), pembrolizumab plus chemotherapy demonstrated statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) versus placebo plus ch
Externí odkaz:
https://doaj.org/article/779d501670554a368c8218be67b35429
Autor:
Daniel G. Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L. Mayer, Mark Jesus M. Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W. Fraser Symmans, Charles Perou, Lisa A. Carey, Ann H. Partridge, Hope S. Rugo
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract Association of stromal tumor-infiltrating lymphocytes (sTILs) with survival outcomes among patients with metastatic breast cancer (MBC) remains unclear. The primary objective was to evaluate the association of sTILs with progression-free sur
Externí odkaz:
https://doaj.org/article/83a9a621c06f4389a3a50e11d37a5714
Autor:
Sana Al Sukhun, Sarah Temin, Carlos H. Barrios, Nicoleta Zenovia Antone, Yanin Chavarri Guerra, Mariana Chavez-MacGregor, Rakesh Chopra, Michael A. Danso, Henry Leonidas Gomez, N’Da Marcelin Homian, Alaa Kandil, Benda Kithaka, Bogda Koczwara, Beverly Moy, Gertrude Nakigudde, Fernando Enrique Petracci, Hope S. Rugo, Nagi S. El Saghir, Banu K. Arun
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSETo guide clinicians and policymakers in three global resource-constrained settings on treating patients with metastatic breast cancer (MBC) when Maximal setting–guideline recommended treatment is unavailable.METHODSA multidisciplinary, multi
Externí odkaz:
https://doaj.org/article/9bac98206ff545daa7a8335a19ffb04e